ANNIBALI, OMBRETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.420
EU - Europa 184
AS - Asia 49
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 2.663
Nazione #
US - Stati Uniti d'America 2.417
IE - Irlanda 69
IT - Italia 49
CN - Cina 29
DE - Germania 15
GB - Regno Unito 15
KR - Corea 8
SE - Svezia 8
UA - Ucraina 6
IN - India 4
RO - Romania 4
RU - Federazione Russa 4
SG - Singapore 4
BR - Brasile 3
CA - Canada 3
CH - Svizzera 3
A1 - Anonimo 2
BE - Belgio 2
EU - Europa 2
FR - Francia 2
HR - Croazia 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
FI - Finlandia 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.663
Città #
Wilmington 833
Houston 714
Fairfield 156
Chandler 155
Ashburn 79
Woodbridge 61
Dublin 60
Seattle 60
Cambridge 44
Medford 42
New York 38
Ann Arbor 28
Beijing 21
Lawrence 20
Rome 16
Dearborn 13
San Diego 10
Seoul 8
Redwood City 7
Creede 6
Milan 6
London 5
Palo Alto 5
Corsico 4
Norwalk 4
Bucharest 3
Center 3
Falls Church 3
Kilburn 3
Latina 3
Mountain View 3
Stony Brook 3
Washington 3
Wellesley 3
Ancenis 2
Brussels 2
Hefei 2
Jacksonville 2
Menlo Park 2
Mülheim 2
Naples 2
Nola 2
Rochester 2
Rosignano Marittimo 2
Shanghai 2
São Paulo 2
Zagreb 2
Amsterdam 1
Augusta 1
Avellino 1
Belgrade 1
Colorado Springs 1
Corona 1
Delhi 1
Deruta 1
Dhaka 1
Foggia 1
Guangzhou 1
Lappeenranta 1
Lima 1
Los Angeles 1
Malo 1
Melbourne 1
Minsk 1
Mugnano Di Napoli 1
Mumbai 1
Nanjing 1
Ottawa 1
Pune 1
Sacramento 1
San Jose 1
Secaucus 1
Suceava 1
Taiyuan 1
Tappahannock 1
Toronto 1
Vancouver 1
Viterbo 1
Zurich 1
Totale 2.480
Nome #
Pulmonary complications and survival after autologous stem cell transplantation: Predictive role of pulmonary function and pneumotoxic medications 257
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 222
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 218
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 184
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 146
Development and initial validation of a questionnaire to assess patients’ perception of protective isolation following haematopoietic stem cell transplantation 144
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 143
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 136
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 135
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 133
Bone marrow aspiration and biopsy-related pain management 127
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 126
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant 123
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network 123
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 121
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 116
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network 105
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 56
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 36
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs 28
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group 26
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy 23
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 20
Totale 2.748
Categoria #
all - tutte 8.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201983 0 0 0 0 0 0 0 0 0 36 22 25
2019/2020844 17 14 28 32 28 40 56 52 159 124 174 120
2020/20211.108 132 137 151 117 119 157 122 108 10 41 6 8
2021/2022222 17 28 6 5 7 41 14 13 9 14 15 53
2022/2023363 28 43 3 37 38 64 61 18 34 14 12 11
2023/2024128 15 5 9 5 22 46 9 7 3 7 0 0
Totale 2.748